Israel’s Teva buys Allergan generic drug company for $40.5B July 27, 2015 Teva Pharmaceutical Industries, the world’s largest maker of generic drugs, said Thursday it had appointed a new chief executive to replace Jeremy Levin, who left abruptly in October.